Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine in acute exacerbation of schizophrenia
NCT01104766Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Apr 2010
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by Forest Laboratories. Started Apr 2010; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01104766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104766.